American Portfolios Advisors’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,135
| Closed | -$227K | – | 3570 |
|
|
2022
Q1 | $227K | Sell |
6,135
-240
| -4% | -$8.86K | 0.01% | 1104 |
|
|
2021
Q4 | $309K | Sell |
6,375
-289
| -4% | -$14K | 0.01% | 952 |
|
|
2021
Q3 | $349K | Buy |
6,664
+950
| +17% | +$49.7K | 0.01% | 876 |
|
|
2021
Q2 | $296K | Hold |
5,714
| – | – | 0.01% | 953 |
|
|
2021
Q1 | $248K | Buy |
+5,714
| New | +$248K | 0.01% | 937 |
|